Product image of Insidon (Opipramol Hydrochloride) supplied by GNH India

Insidon

Active Ingredient:
Opipramol Hydrochloride
Origin:
EU

Insidon (Opipramol Hydrochloride)

Opipramol Hydrochloride, the active ingredient in Insidon, is a tricyclic antidepressant presented as an oral dosage form for oral use. It is employed in the management of generalized anxiety disorder and depressive disorders, helping to alleviate symptoms in adult patients.
GNH India supplies Insidon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratoires Juvise Pharmaceuticals

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Opipramol Hydrochloride is used in the treatment of anxiety‑related and mood disorders, acting on central neurotransmitter pathways.

  • Generalized anxiety disorder: reduces anxiety symptoms and improves overall functioning.
  • Major depressive disorder: alleviates depressive mood and associated symptoms.
  • Mixed anxiety‑depressive states: provides combined anxiolytic and antidepressant effects.

How It Works

  • Opipramol Hydrochloride acts primarily as a sigma‑1 receptor agonist while also modulating serotonergic and noradrenergic neurotransmission. This dual activity leads to enhanced neuronal inhibition and mood regulation, producing anxiolytic and antidepressant effects without significant direct monoamine reuptake inhibition.

Side Effects

Opipramol Hydrochloride may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects

  • Drowsiness: feeling unusually sleepy or fatigued.
  • Dry mouth: reduced salivation leading to a dry oral cavity.
  • Constipation: decreased bowel movements or difficulty passing stool.
  • Weight gain: modest increase in body weight over time.
  • Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects

  • Cardiac arrhythmia: irregular heart rhythm requiring medical attention.
  • Severe hypotension: marked drop in blood pressure causing faintness.
  • Hepatotoxicity: liver enzyme elevations or liver injury.
  • Allergic reactions: rash, itching, swelling, or difficulty breathing.
  • Suicidal ideation: emergence or worsening of thoughts of self‑harm.

Precautions & Warnings

Before initiating therapy with Opipramol Hydrochloride, consider patient‑specific factors and monitor for potential risks.

  • Renal impairment: adjust use if severe kidney dysfunction is present.
  • Hepatic disease: exercise caution in patients with liver disorders.
  • Elderly patients: start with lower doses due to increased sensitivity.
  • Concomitant CNS depressants: avoid additive sedation.
  • Pregnancy and lactation: weigh benefits against potential risks; consult obstetric guidance.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Opipramol Hydrochloride can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • MAO inhibitors: risk of severe hypertension or serotonin syndrome.
  • CNS depressants (e.g., benzodiazepines, alcohol): profound sedation and respiratory depression.

Moderate Interactions (Monitor Closely):\n- Antihypertensives: additive blood‑pressure lowering effect.

  • Anticholinergic agents: increased risk of dry mouth and constipation.
  • CYP450 substrates: potential alteration of metabolism for drugs processed by the same enzymes.

Frequently Asked Questions

Insidon contains Opipramol Hydrochloride and is prescribed for generalized anxiety disorder and various depressive disorders. It helps reduce anxiety symptoms and improve mood in adult patients, offering both anxiolytic and antidepressant benefits as part of a comprehensive treatment plan.

Opipramol Hydrochloride primarily activates sigma‑1 receptors and modulates serotonin and norepinephrine pathways. This combined action enhances neuronal inhibition and stabilises mood, leading to reduced anxiety and depressive symptoms without directly blocking monoamine reuptake.

The appropriate dose of Insidon is determined by the prescribing healthcare professional based on the individual’s clinical condition, response, and tolerability. Dosage adjustments are made according to therapeutic goals and any relevant patient factors.

Safety of Opipramol Hydrochloride during pregnancy or lactation has not been definitively established. Prescribers should evaluate the potential benefits against possible risks and consider alternative therapies when appropriate. Consultation with obstetric specialists is recommended.

To request Insidon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with typical benzodiazepines, Insidon (Opipramol) offers anxiolytic effects without strong dependence potential, but it may cause more sedation. Unlike selective serotonin reuptake inhibitors, its mechanism involves sigma‑1 receptor activation, providing a distinct therapeutic profile that can be useful in patients who do not respond to first‑line agents.

Insidon should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Insidon is taken orally, usually with a glass of water. The exact timing (e.g., with or without food) should follow the prescriber’s instructions, as absorption can be influenced by meals in some patients.

Serious risks include cardiac arrhythmias, severe hypotension, hepatotoxicity, allergic reactions such as rash or breathing difficulty, and emergence or worsening of suicidal thoughts. Patients should seek immediate medical attention if any of these symptoms occur.

Insidon is contraindicated in patients with known hypersensitivity to Opipramol Hydrochloride, those currently taking monoamine oxidase inhibitors, and individuals with severe hepatic or renal impairment where the drug’s safety cannot be assured. Consultation with a healthcare provider is essential before starting therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Opipramol Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT